Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled DNase for lower respiratory tract infection in children with tracheobronchomalacia
NL-OMON20292Active, not recruiting
- Sponsor
- Erasmus MC Sophia Children's Hospital
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of dornase alfa in pulmonary infection (2 arms), sponsored by Erasmus MC Sophia Children's Hospital. Primary endpoint: Decrease in mean daily Cough Symptom Score. Started Sep 2005; status: active, not recruiting.
02
Drugs
dornase alfa
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on NL-OMON20292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20292.